Pharmacy Technician: Controlled Substance Diversion Prevention and Detection Microcredential

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This pharmacy technician microcredential is intended for pharmacy technicians seeking to expand their knowledge about the prevention, identification, and response to controlled substance diversion in healthcare settings; and for those preparing to take the PTCB Controlled Substances Diversion Certificate exam.

ACPE: 0204-0000-26-728-H04-T
Knowledge-based
2 contact hours

Learning Objectives:

• Discuss the consequences of controlled substance (CS) diversion.
• Describe the signs of an impaired healthcare worker.
• Explain the motivations to divert CS.
• List areas of vulnerability in procurement, preparation and dispensing, prescribing, administration, and waste/removal processes.
• Discuss the elements of a comprehensive and effective controlled substances diversion prevention program (CSDPP).
• Explain the types and functions of security control measures, devices, and software to detect and prevent diversion.
• Recognize the high-risk areas of the pharmacy and other departments.
• Describe chain of custody methods as they relate to controlled substances.
• Discuss DEA registration requirements.
• Review the contents, appropriate usage, and record keeping for all applicable DEA forms.
• Explain the DEA Controlled Substance Ordering System (CSOS).
• Explain the DEA controlled substance list including those that are at a high risk for diversion.
• List the DEA requirements for conducting physical inventories and record keeping.
• Describe the actions to take during a robbery or theft event.
• Recognize the procedures required for sales of CS and restricted OTCs.
• Recognize suspicious data patterns.
• Explain surveillance practices and techniques.
• Describe signs of product tampering/alteration.
• Recognize signs and methods to detect fraudulent prescriptions.

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

• No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.

Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.